Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
Mita
K
K
Department of Surgery, University of Tokyo, Japan.
Akiyama
N
N
Nagao
T
T
Sugimoto
H
H
Inoue
S
S
Osakabe
T
T
Nakayama
Y
Y
Yokota
K
K
Sato
K
K
Uchida
H
H
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use*
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine